The long-term stability of an active-pharmaceutical ingredient and its drug products plays an
important role in the licensing process of new pharmaceuticals and for the application of the …

Prasugrel was subjected to forced degradation studies under conditions of hydrolysis (acid,
base, and neutral), photolysis, oxidation, and thermal stress. The drug showed liability in …

A simple, sensitive, specific, accurate, and stability-indicating reversed phase high
performance liquid chromatographic method was developed for the simultaneous …

In this study, a mesoporous carbon-based electrochemical sensor has been made up,
possessing the novelty for ultra-sensitive detecting Prasugrel in pharmaceutical formulation …

Prasugrel hydrochloride is the active ingredient in Effient™, a thienopyridine platelet
inhibitor. An extensive study of the degradation chemistry of prasugrel hydrochloride …

A comprehensive profile of prasugrel HCl is reported herein with 158 references. A full
description including nomenclature, formulae, elemental analysis, and appearance is …

Current study develops and validates a dissolution test for Prasugrel hydrochloride 10 mg in
coated tablets. After sink condition, filters and drug stability were evaluated, the …

The prasugrel characterization of reference substance described in this work ensures its
purity and identity. The melting point by DSC (122.03 C) and capillary method (120.5-121.9 …

A gradient reverse-phase high performance liquid chromatographic (RP-HPLC) method has
been developed and validated for the determination of Prasugrel hydrochloride and its …

A stability-indicating RP-LC method for the determination of prasugrel in tablets was
developed and validated. Stress testing of prasugrel was carried out in accordance with ICH …